Investing.com -- Entera Bio Ltd. (NASDAQ:ENTX) stock rose 3.5% in Thursday’s premarket trading following the company’s presentation of new clinical data from its Phase 2 trial of EB613, an oral ...

Consistency of BMD gains presented at NAMS 2025 demonstrate EB613’s efficacy in both young postmenopausal women and in women 10 years ...

Researchers said infrequent zoledronate infusions could be an attractive, lifelong therapy for women at low-risk for fracture ...

The Dubai Civil Aviation Authority (DCAA) concluded the inaugural edition of the Aviation Safety Transformation Summit 2025, ...

The Supreme Organising Committee of the Open Masters Games Abu Dhabi 2026 has announced the launch of the Open Masters Games ...

This recipe explores how to smoke a tomahawk ribeye steak using the reverse sear method to achieve optimal tenderness and ...

Think of your bones as living tissue that responds to force. When muscles pull on bones, or when bone handles load (as in ...

New review finds yogurt provides nutrients but offers minimal real-world benefits for bone strength or fracture prevention in ...

Entera Bio (ENTX) reported new clinical data from a post-hoc analysis of its Phase 2 trial of EB613, at the 2025 North American Menopause Society ...

The Allan Labor Government is upgrading one of the west's busiest intersections, with a major milestone reached on the Point Cook Road and Central ...

Star playmaker Kirra Dibb is set to join a new club after being granted an immediate release by the Cowboys from the ...